City

Amsterdam (1)

Boston (1)

Los Angeles (1)

Uppsala (1)

Condition

Arterial Inflammation (3)

Cardiovascular Diseases (2)

Atherosclerosis (1)

Atherosclerotic Cardiovascular Disease (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Terminated (1)

Sign in for free

Phase

n/a (1)

phase 2 (1)

Sponsor

Athera Biotechnologies AB (1)

Massachusetts General Hospital (1)

University of California, Los Angeles (1)

Collaborator

Intervention

99mtc-tilmanocept spect/ct scanning (1)

contrast-enhanced ccta (1)

no drug or device, only a test. the test is called a pet/ct (1)

pc-mab (1)

placebo (1)

Study Documents

Intervention Type

other (2)

drug (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational (1)

arterial inflammation

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Immunomodulatory Effects of PCSK9 Inhibition

Not yet recruiting

Atherosclerotic Cardiovascular Disease
+3 more

Contrast-enhanced CCTA
99mTc-tilmanocept SPECT/CT scanning

Boston, Massachusetts

Massachusetts General Hospital

Jan 30, 2023

Arterial Inflammation Trial in Los Angeles (No drug or device, only a test. The test is called a PET/CT)

Recruiting

Arterial Inflammation

No drug or device, only a test. The test is called a PET/CT

Los Angeles, California

UCaliforniaLA

Mar 9, 2021

Arterial Inflammation, Cardiovascular Diseases Trial in Amsterdam, Uppsala (PC-mAb, Placebo)

Terminated

Arterial Inflammation
Cardiovascular Diseases

PC-mAb
Placebo

Amsterdam, Netherlands
+1 more

Jul 4, 2018